[Combination of methotrexate injection through hysteroscopic tubal catheterization and mifepristone per os in the conservative treatment of tubal pregnancy].
OBJECTIVE
To evaluate the value of the combination of methotrexate(MTX) injection through hysteroscopic tubal catheterization and mifepristone per os in the conservative treatment of tubal pregnancy.


METHODS
Forty patients who met the criteria of conservative treatment were enrolled in this study and received the combined therapy of MTX 50 mg/d injection through hysteroscopic tubal catheterization and oral mifepristone 100mg/d for 5 days.


RESULTS
Of these 40 patients, 38 (95.0%) were cured. The human chorionic gonadotropin decreased to normal level within 3-48 days. The masses disappeared within 16-65 days. The menstruation returned normal within 28-42 days. No obvious side effect was observed. Of 30 patients who underwent hydrotubation through hysteroscopy three months later, 12 patients were unobstructed, 2 patients were completely obstructed, and 16 patients were partially obstructed. Five patients had full-term deliveries up to this report.


CONCLUSIONS
The combination of MTX injection through hysteroscopic tubal catheterization and mifepristone per os is safe and effective for early tubal pregnancy.
Zhao
Hui
H
Deparment of Obestetrics and Gynecology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Yang
Bao-Jun
BJ
Feng
Li-Min
LM
D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D007267:Injections; D008727:Methotrexate / Q000008:administration & dosage* / Q000627:therapeutic use; D015735:Mifepristone / Q000627:therapeutic use*; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000188:drug therapy*; D055815:Young Adult
D015735:Mifepristone; D008727:Methotrexate